Examination of additive effects of dulaglutide and empagliflozin to type 2 diabetic patients with poor glycemic control despite insulin administration.
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000024703
- Lead Sponsor
- Social medical corporations Aijinkai Chibune hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with 75 years old and over,category 2,3. Patients who have not taken medicine for 3 months and over. Patients with impaired liver or kidney functions,who need adjustment of medicine.Patients with collagen disease or cancer.Patients who have economic reasons,and judged not to be appropriate by doctors.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c(%) For patients of 65 years old and over,we follow HbA1c with causion to lower limit.
- Secondary Outcome Measures
Name Time Method We assess body weight,accomplishment rates of HbA1c under 7%,blood pressure,renal function,and body fat.